Contact Molecules for Homologous Proteins | ||||
![]() [Full Bars] |
![]() [SiteTable] |
|
![]() [Back to Search Page] |
![]() [Back to HOMCOS] |
![]() [help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | ![]() [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
1700469 | 362 | 500 | P01889(HLAB_HUMAN) | RecName: Full=HLA class I histocompatibility antigen, B alpha chain;AltName: Full=Human leukocyte antigen B; Short=HLA-B;Flags: Precursor; |
QUERYSEQ |
MLVMAPRTVLLLLSAALALTETWAGSHSMRYFYTSVSRPGRGEPRFISVGYVDDTQFVRFDSDAASPREEPRAPWIEQEGPEYWDRNTQIYKAQAQTDRESLRNLRGYYNQSEAGSHTLQSMYGCDVGPDGRLLRGHDQYAYDGKDYIAL NEDLRSWTAADTAAQITQRKWEAAREAEQRRAYLEGECVEWLRRYLENGKDKLERADPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEP SSQSTVPIVGIVAGLAVLAVVVIGAVVAAVMCRRKSSGGKGGSYSQAACSDSAQGSDVSLTA |
362 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
region | name | description |
![]() ![]() |
1-24 | SIGNAL | |
![]() ![]() |
25-362 | CHAIN | /note="HLA class I histocompatibility antigen, B alpha chain" /id="PRO_0000018833" |
![]() ![]() ![]() |
25-309 | TOPO_DOM | /note="Extracellular" |
![]() ![]() ![]() |
310-333 | TRANSMEM | /note="Helical" |
![]() ![]() |
334-362 | TOPO_DOM | /note="Cytoplasmic" |
![]() ![]() ![]() |
209-295 | DOMAIN | /note="Ig-like C1-type" |
![]() ![]() ![]() |
25-114 | REGION | /note="Alpha-1" |
![]() ![]() ![]() |
115-206 | REGION | /note="Alpha-2" |
![]() ![]() ![]() |
207-298 | REGION | /note="Alpha-3" |
![]() ![]() ![]() |
299-309 | REGION | /note="Connecting peptide" |
![]() ![]() |
337-362 | REGION | /note="Disordered" |
![]() ![]() |
339-362 | COMPBIAS | /note="Polar residues" |
![]() ![]() ![]() |
87-87 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
108-108 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
167-167 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
170-170 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
176-176 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
183-183 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() |
195-195 | BINDING | /ligand="a peptide antigen" /ligand_id="ChEBI:CHEBI:166823" /ligand_note="pathogen-derived peptide antigen" |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
1-362 | DISORDER | predicted by DISOPRED |
![]() |
|||||||
362 | |||||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
pdb_id | a1 | identity[%]2 | description | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | 1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha chain | |||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
![]() |
|||||||
362 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | F5HB26_HCMV peptide from Tegument protein pp65[11 aa] | A | 100.0 /100.0 |
30 /30 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RFL9 peptide[9 aa] | A | 100.0 /100.0 |
27 /27 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RL9 peptide[9 aa] | A | 100.0 /100.0 |
27 /27 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | SPI peptide from Influenza A virus[9 aa] | A | 100.0 /100.0 |
29 /29 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RPP peptide from EBV[9 aa] | A | 100.0 /100.0 |
28 /28 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TPR peptide from CMV[10 aa] | A | 100.0 /100.0 |
26 /26 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTG1B_HUMAN Cancer/testis antigen 1 peptide[13 aa] | A | 100.0 /100.0 |
24 /24 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | A0A0B4J268_HUMAN T-cell receptor alpha variable 4,TCR alpha chain[2.. | E | 100.0 /100.0 |
7 /7 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | A0A5B6_HUMAN T-cell receptor beta variable 28,TCR beta chain[24.. | E | 100.0 /100.0 |
4 /4 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | A0A0B4J268_HUMAN T-cell receptor alpha variable 4,TCR alpha chain[1.. | D | 100.0 /100.0 |
11 /11 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | IDHP_HUMAN Isocitrate dehydrogenase [NADP], mitochondrial[10 .. | A | 100.0 /100.0 |
26 /26 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | IDHP_HUMAN Isocitrate dehydrogenase [NADP], mitochondrial[10 .. | A | 100.0 /100.0 |
30 /30 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Fab heavy chain[218 aa] | A | 100.0 /100.0 |
14 /14 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | HD14 alpha chain[203 aa] | A | 100.0 /100.0 |
9 /9 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | HD14 beta chain[243 aa] | A | 100.0 /100.0 |
7 /7 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | R1AB_SARS2 ORF1ab[9 aa] | A | 100.0 /100.0 |
27 /27 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_SARS Nucleoprotein[9 aa] | A | 100.0 /100.0 |
30 /30 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | NCAP_CVH22 Nucleoprotein peptide N75-83[9 aa] | A | 100.0 /100.0 |
28 /28 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | KMT2A_HUMAN MLL cleavage product N320 peptide[9 aa] | A | 100.0 /100.0 |
28 /28 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | KMT2A_HUMAN MLL cleavage product N320 phosphopeptide[9 aa] | A | 100.0 /100.0 |
27 /27 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DOT1L_HUMAN Histone-lysine N-methyltransferase, H3 lysine-79 s.. | A | 100.0 /100.0 |
29 /29 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DOT1L_HUMAN Histone-lysine N-methyltransferase, H3 lysine-79 s.. | A | 100.0 /100.0 |
29 /29 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q70A36_9HIV1 GAG protein[9 aa] | A | 100.0 /100.0 |
23 /23 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POL_HV1BR Gag-Pol polyprotein[9 aa] | A | 85.2 /98.2 |
27 /27 |
V6E0U6_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | beta chain T18A TCR[241 aa] | A | 100.0 /97.5 |
9 /9 |
I3ZN85_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | alpha chain T18A TCR[201 aa] | A | 100.0 /97.5 |
4 /4 |
I3ZN85_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | alpha chain T18A TCR[202 aa] | A | 100.0 /98.2 |
4 /4 |
V6E0U6_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q90VG9_9HIV1 Protein Nef[9 aa] | A | 100.0 /100.0 |
30 /30 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q90VG9_9HIV1 Protein Nef[9 aa] | A | 90.0 /98.2 |
30 /30 |
1B42_HUMAN HLA class I histocompatibility antigen, B-42 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | T2D0U8_9HIV1 Vpr protein[9 aa] | A | 85.7 /97.8 |
28 /28 |
1B81_HUMAN HLA class I histocompatibility antigen, B-81 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | RL42 T cell receptor, alpha chain[197 aa] | A | 77.8 /95.7 |
9 /9 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | RL42 T cell receptor, beta chain[241 aa] | A | 80.0 /95.7 |
5 /5 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV-1 GAG PEPTIDE (GGRKKYKL - 3R MUTATION)[8 aa] | A | 81.5 /95.7 |
27 /27 |
1B08_HUMAN B*0801 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV-1 GAG PEPTIDE (GGKKKYQL - 7Q MUTATION)[8 aa] | A | 81.5 /95.7 |
27 /27 |
1B08_HUMAN B*0801 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV-1 GAG PEPTIDE (GGKKKYKL - INDEX PEPTIDE)[8 aa].. | A | 76.9 /95.7 |
26 /26 |
1B08_HUMAN B*0801 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV-1 GAG PEPTIDE (GGKKKYRL - 7R MUTATION)[8 aa] | A | 77.8 /95.7 |
27 /27 |
1B08_HUMAN B*0801 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV-1 GAG PEPTIDE (GGKKRYKL - 5R MUTATION)[8 aa] | A | 79.3 /95.7 |
29 /29 |
1B08_HUMAN B*0801 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | CF34 alpha chain[202 aa] | A | 90.0 /95.7 |
10 /10 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | BZLF1_EBVB9 peptide from Trans-activator protein BZLF1[8 aa] | A | 73.3 /95.7 |
30 /30 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DD31 TCR alpha chain[203 aa] | A | 92.3 /95.7 |
13 /13 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | DD31 TCR alpha chain[202 aa] | F | 100.0 /95.7 |
14 /14 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9YRL3_HCMV Major immediate-early protein[9 aa] | A | 77.8 /95.7 |
36 /36 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | VIE1_HCMVT 55 kDa immediate-early protein 1[9 aa] | A | 81.2 /95.7 |
32 /32 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | EBNA3_EBVG Epstein-Barr nuclear antigen 3[9 aa] | A | 83.3 /95.6 |
30 /30 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | X2G898_9HEPC NS3-4A protein[9 aa] | A | 82.1 /95.7 |
28 /28 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | QIK peptide from CMV[9 aa] | A | 78.1 /95.5 |
32 /32 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ELR peptide from IAV[9 aa] | A | 78.1 /95.3 |
32 /32 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MHC I-peptide[9 aa] | A | 73.3 /95.3 |
30 /30 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MHC I-peptide[9 aa] | A | 71.4 /95.3 |
28 /28 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MHC I-peptide[9 aa] | A | 73.1 /95.3 |
26 /26 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MHC I-peptide[9 aa] | A | 71.4 /95.3 |
28 /28 |
R4ZGR5_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PHE-ALA-LYS-LYS-LYS-TYR-CYS-LEU[8 aa] | A | 72.4 /95.3 |
29 /29 |
R4ZGR5_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PHE-VAL-LYS-LYS-LYS-TYR-CYS-LEU[8 aa] | A | 73.3 /95.3 |
30 /30 |
R4ZGR5_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ALA-PHE-ALA-LYS-LYS-LYS-TYR-CYS-LEU[9 aa] | A | 76.7 /95.2 |
30 /30 |
A0A3G6II09_HUMAN MHC class I protein (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | peptide RARARARARARAFVKKKYCL[10 aa] | A | 72.4 /94.9 |
29 /29 |
R4ZGR5_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | EBN3_EBV EBNA-3 nuclear protein[9 aa] | A | 80.6 /95.5 |
31 /31 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 B*0801.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DDX3X_HUMAN Peptide from ATP-dependent RNA helicase DDX3X[10 a.. | A | 76.7 /94.5 |
30 /30 |
1B39_HUMAN HLA class I histocompatibility antigen, B-39 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DDX3X_HUMAN Peptide from ATP-dependent RNA helicase DDX3X[9 aa.. | A | 85.7 /94.5 |
28 /28 |
1B39_HUMAN HLA class I histocompatibility antigen, B-39 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DDX3X_HUMAN Peptide from ATP-dependent RNA helicase DDX3X[8 aa.. | A | 76.9 /94.5 |
26 /26 |
1B39_HUMAN HLA class I histocompatibility antigen, B-39 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LMP2_EBV GENE TERMINAL PROTEIN (MEMBRANE PROTEIN LMP-2A/LMP.. | A | 58.6 /92.8 |
29 /29 |
1B27_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN B-27 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LMP2_EBV Latent membrane protein 2 peptide[9 aa] | A | 78.1 /94.2 |
32 /32 |
Q56H30_HUMAN HLA class I histocompatibility antigen, B*1402 alp.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PPGB_HUMAN nonameric peptide from Lysosomal protective protei.. | A | 65.5 /92.8 |
29 /29 |
1B27_HUMAN HLA class I histocompatibility antigen, B-27 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PPGB_HUMAN Cathepsin A signal sequence octapeptide[9 aa] | A | 78.6 /94.2 |
28 /28 |
Q56H30_HUMAN HLA-B*1402 extracellular domain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ARG-GLU-PHE-SER-LYS-GLU-PRO-GLU-LEU[9 aa] | A | 72.4 /93.8 |
29 /29 |
1B40_HUMAN HLA class I histocompatibility antigen, B-40 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | dengue1 poly peptide[9 aa] | A | 76.9 /93.8 |
26 /26 |
1B46_HUMAN HLA class I histocompatibility antigen, B-46 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | BZLF1_EBVG Trans-activator protein BZLF1[8 aa] | A | 69.0 /93.5 |
29 /29 |
1B18_HUMAN HLA class I histocompatibility antigen, B-18 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ASP-GLU-LEU-GLU-ILE-LYS-ALA-TYR[8 aa] | A | 70.0 /93.5 |
30 /30 |
1B18_HUMAN HLA class I histocompatibility antigen, B-18 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | E9PM67_HUMAN Inner centromere protein[9 aa] | A | 69.0 /93.5 |
29 /29 |
1B40_HUMAN HLA class I histocompatibility antigen, B-40 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MTAP_HUMAN 11-mer peptide from S-methyl-5'-thioadenosine phos.. | A | 74.2 /93.4 |
31 /31 |
1B41_HUMAN HLA class I histocompatibility antigen, B-41 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | B6D4Y8_HUMAN Tyrosine-protein kinase receptor[10 aa] | A | 71.9 /93.1 |
32 /32 |
1B15_HUMAN HLA class I histocompatibility antigen, B-15 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | EBN3_EBV EBNA-3 nuclear protein[9 aa] | A | 75.9 /93.1 |
29 /29 |
1B15_HUMAN HLA class I histocompatibility antigen, B-15 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | UB2E1_HUMAN Ubiquitin-conjugating enzyme E2 E1[9 aa] | A | 75.9 /93.1 |
29 /29 |
1B15_HUMAN HLA class I histocompatibility antigen, B-15 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Peptide antigen[9 aa] | A | 74.2 /93.1 |
31 /31 |
1B15_HUMAN HLA class I histocompatibility antigen, B-15 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | anapestic lymphoma kinase-derived neuroblastoma tu.. | A | 70.0 /93.1 |
30 /30 |
1B15_HUMAN HLA class I histocompatibility antigen, B-15 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Synthetic peptide HIS-LEU-ALA-SER-SER-GLY-HIS-SER-.. | A | 84.6 /92.4 |
26 /26 |
F4NBQ8_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Synthetic peptide HIS-LEU-ALA-SER-SER-GLY-HIS-SER-.. | A | 75.9 /92.4 |
29 /29 |
F4NBQ8_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NQK-OC43 peptide[9 aa] | A | 72.4 /93.1 |
29 /29 |
heavy chain HLA-B*15:01 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S2' [9 aa] | A | 70.0 /93.1 |
30 /30 |
heavy chain HLA-B*15:01 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HNRPC_HUMAN 16-mer peptide from Heterogeneous nuclear ribonucl.. | A | 70.4 /93.1 |
27 /27 |
1B41_HUMAN HLA class I histocompatibility antigen, B-41 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GLY-GLU-THR-ALA-LEU-ALA-LEU-LEU-LEU-LEU[10 aa] | A | 60.7 /93.1 |
28 /28 |
F4NBU6_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | M1_INBYA 9-mer peptide from Matrix protein 1[9 aa] | A | 67.9 /93.1 |
28 /28 |
F4NBQ1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MODEL PEPTIDE SEQUENCE - ARAAAAAAA[9 aa] | A | 70.0 /92.8 |
20 /20 |
1B27_HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-B*2705) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | peptide s10R[10 aa] | A | 71.9 /92.8 |
32 /32 |
1B27_HUMAN HUMAN LYMPHOCYTE ANTIGEN HLA-B27 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | peptide m9[9 aa] | A | 56.5 /92.8 |
23 /23 |
1B27_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-27 B*270.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | VIPR_HUMAN VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR[9 aa] | A | 70.0 /92.8 |
30 /30 |
Q29846 HUMAN LYMPHOCYTE ANTIGEN HLA-B27 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TISD_HUMAN BUTYRATE RESPONSE FACTOR 2[9 aa] | A | 66.7 /92.8 |
30 /30 |
1B27_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | THE GLUCAGON RECEPTOR (GR) PEPTIDE[9 aa] | A | 64.3 /92.8 |
28 /28 |
1B27_HUMAN HLA class I histocompatibility antigen, B-27 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | EBN6_EBV EPSTEIN-BARR NUCLEAR ANTIGEN-6[9 aa] | A | 69.2 /92.8 |
26 /26 |
1B27_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-27 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q8B2U6_9INFA INFLUENZA NUCLEOPROTEIN[9 aa] | A | 66.7 /92.8 |
27 /27 |
1B27_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-27 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | VIPR1_HUMAN Vasoactive intestinal polypeptide receptor 1[9 aa].. | A | 67.7 /92.8 |
31 /31 |
1B27_HUMAN HLA class I histocompatibility antigen, B-27 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Double citrullinated vasoactive intestinal polypep.. | A | 64.5 /92.8 |
31 /31 |
A3F718_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CAC1D_HUMAN 9-meric peptide from Voltage-dependent L-type calc.. | A | 64.5 /92.8 |
31 /31 |
1B27_HUMAN HLA class I histocompatibility antigen, B-27 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | beta chain of the TK3 TCR[241 aa] | A | 100.0 /92.0 |
6 /6 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | A0A0B4J1U6_HUMAN T-cell receptor beta variable 9,TCR beta chain[245.. | D | 100.0 /100.0 |
8 /8 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | alpha chain C12C TCR[204 aa] | A | 100.0 /92.8 |
7 /7 |
1B27_HUMAN HLA class I histocompatibility antigen, B-27 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9YNZ1_9HIV1 Gag protein[10 aa] | A | 64.3 /92.8 |
28 /28 |
1B27_HUMAN HLA class I histocompatibility antigen, B-27 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 11-mer peptide[11 aa] | A | 72.4 /92.8 |
29 /29 |
O78189_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 14-mer peptide[10 aa] | A | 66.7 /92.8 |
30 /30 |
O78189_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 13-mer peptide[10 aa] | A | 66.7 /92.8 |
27 /27 |
O78189_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GLY-ARG-LEU-ASN-ALA-PRO-ILE-LYS-VAL[9 aa] | A | 65.2 /92.8 |
23 /23 |
A3F718_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GLY-ARG-LEU-ASN-GLU-PRO-ILE-LYS-VAL[9 aa] | A | 61.9 /92.8 |
21 /21 |
A3F718_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | mQ[9 aa] | A | 66.7 /92.8 |
24 /24 |
A3F718_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | VIPR1_HUMAN Vasoactive intestinal polypeptide receptor 1[9 aa].. | A | 65.4 /92.8 |
26 /26 |
A0A2R7Z5J3_HUMAN Lymphocyte antigen HLA-B27 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ARG-ARG-PHE-SER-ARG-SER-PRO-ILE-ARG-ARG[10 aa] | A | 66.7 /92.8 |
27 /27 |
A3F718_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ARG-ARG-PHE-SEP-ARG-SER-PRO-ILE-ARG-ARG[10 aa] | A | 64.5 /92.8 |
31 /31 |
A3F718_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ARG-ARG-PHE-SEP-ARG-SEP-PRO-ILE-ARG[9 aa] | A | 70.4 /92.8 |
27 /27 |
A3F718_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ARG-ARG-PHE-SEP-ARG-SEP-PRO-ILE-ARG-ARG[10 aa] | A | 67.9 /92.8 |
28 /28 |
A3F718_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Pre-MRNA Processing Factor 3[9 aa] | B | 64.0 /92.7 |
25 /25 |
A3F718_HUMAN Human leukocyte antigen (HLA) B27 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T cell receptor alpha chain[196 aa] | B | 100.0 /92.7 |
9 /9 |
A3F718_HUMAN Human leukocyte antigen (HLA) B27 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | YeiH protein[9 aa] | B | 67.9 /92.8 |
28 /28 |
A3F718_HUMAN Human leukocyte antigen (HLA) B27 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | YEIH[9 aa] | A | 70.4 /92.8 |
27 /27 |
A3F718_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | AS4.3 T cell receptor alpha chain[197 aa] | A | 100.0 /92.4 |
9 /9 |
A3F718_HUMAN Human leukocyte antigen (HLA) B27 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T cell receptor alpha chain[181 aa] | B | 100.0 /92.8 |
10 /10 |
A3F718_HUMAN Human leukocyte antigen (HLA) B27 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PHE-ARG-TYR-ASN-GLY-LEU-ILE-HIS-ARG peptide[9 aa] | A | 64.5 /92.8 |
31 /31 |
A3F718_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | IgG2a heavy chain[215 aa] | A | 100.0 /92.8 |
9 /9 |
A3F718_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | Light chain kappa[211 aa] | A | 100.0 /92.8 |
5 /5 |
A3F718_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | AS8.4a[206 aa] | A | 100.0 /92.8 |
10 /10 |
A3F718_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 8-mer peptide[6 aa] | A | 68.8 /92.7 |
16 /16 |
O78189_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 7-mer peptide[7 aa] | A | 63.2 /92.7 |
19 /19 |
O78189_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | 6-mer peptide[6 aa] | A | 66.7 /92.7 |
18 /18 |
O78189_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | EBV-peptide LPEPLPQGQLTAY[13 aa] | A | 69.7 /92.0 |
33 /33 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | SB27 T cell receptor alpha chain[204 aa] | A | 83.3 /92.4 |
6 /6 |
HLA-B35 variant |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV PEPTIDE[10 aa] | A | 61.5 /92.8 |
26 /26 |
1B27_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN B-27 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | EBN1_EBV 11-mer peptide from Epstein-Barr nuclear antigen 1.. | A | 81.5 /92.4 |
27 /27 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PP65_HCMVA CPS peptide from 65 kDa lower matrix phosphoprotei.. | A | 77.4 /92.4 |
31 /31 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PP65_HCMVA FPT peptide from 65 kDa lower matrix phosphoprotei.. | A | 83.3 /92.4 |
24 /24 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Latent membrane protein 2[9 aa] | A | 67.9 /92.4 |
28 /28 |
1B27_HUMAN HLA class I histocompatibility antigen, B-27 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LPEP peptide from EBV, P4A, LPEALPQGQLTAY[13 aa] | A | 75.8 /92.4 |
33 /33 |
C5MK56_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LPEP peptide from EBV, P5A, LPEPAPQGQLTAY[13 aa] | A | 72.7 /92.4 |
33 /33 |
C5MK56_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LPEP peptide from EBV, P6A, LPEPLAQGQLTAY[13 aa] | A | 72.7 /92.4 |
33 /33 |
C5MK56_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LPEP peptide from EBV, P7A, LPEPLPAGQLTAY[13 aa] | A | 73.5 /92.4 |
34 /34 |
C5MK56_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LPEP peptide from EBV, P9A, LPEPLPQGALTAY[13 aa] | A | 71.9 /92.4 |
32 /32 |
C5MK56_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LPEP peptide from EBV, P10A, LPEPLPQGQATAY[13 aa] | A | 70.0 /92.4 |
30 /30 |
C5MK56_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | SB47 TCR alpha chain[201 aa] | A | 91.7 /92.4 |
12 /12 |
C5MK56_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | EBNA1_EBVG Epstein-Barr nuclear antigen 1[11 aa] | A | 71.9 /92.0 |
32 /32 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LRN peptide[9 aa] | A | 72.4 /92.8 |
29 /29 |
1B27_HUMAN HLA class I histocompatibility antigen, B-27 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Synthetic peptide THR-VAL-ARG-ALA-SER-GLY-HIS-SER-.. | A | 75.0 /92.4 |
28 /28 |
F4NBQ8_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Synthetic peptide GLU-LEU-ARG-ALA-ARG-GLU-GLU-SER-.. | A | 75.9 /92.4 |
29 /29 |
F4NBQ8_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Synthetic peptide GLU-LEU-ARG-ALA-ARG-GLU-GLU-ALA-.. | A | 74.2 /92.4 |
31 /31 |
F4NBQ8_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Synthetic peptide GLU-LEU-ARG-ALA-ARG-GLN-GLU-CYS-.. | A | 73.3 /92.4 |
30 /30 |
F4NBQ8_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Synthetic peptide THR-VAL-ALA-ALA-SER-GLY-HIS-SER-.. | A | 72.4 /93.1 |
29 /29 |
F4NBQ1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Synthetic peptide THR-VAL-ALA-ALA-SER-GLY-HIS-SER-.. | A | 76.7 /92.4 |
30 /30 |
F4NBQ8_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Ribonuclease H2 subunit B[9 aa] | A | 69.6 /92.4 |
23 /23 |
A3F718_HUMAN Human leukocyte antigen (HLA) B27 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | aa 4-17 (LPAVVGLSPGEQEY) of alternative reading fr.. | A | 71.9 /92.0 |
32 /32 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | BZLF1_EBV BZLF1 trans-activator protein[11 aa] | A | 75.0 /92.0 |
32 /32 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | BZLF1_EBV 10-mer peptide from BZLF1 trans-activator protein[.. | A | 73.3 /92.4 |
30 /30 |
1B35_HUMAN HLA class I histocompatibility antigen, B*3508 hea.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PEPTIDE[9 aa] | A | 72.4 /92.0 |
29 /29 |
1B35_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN B-35 ALPHA .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | EBN1_EBV 11-mer peptide from Epstein-Barr nuclear antigen 1.. | A | 80.8 /92.0 |
26 /26 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | ELS4 TCR alpha chain[188 aa] | A | 90.0 /92.0 |
10 /10 |
O19626_HUMAN HLA-B35 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | ELS4 TCR beta chain[243 aa] | A | 87.5 /92.0 |
8 /8 |
O19626_HUMAN HLA-B35 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NP418 epitope from 1918 influenza strain[9 aa] | A | 84.0 /92.0 |
25 /25 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NP418 epitope from 1934 influenza strain[9 aa] | A | 77.8 /92.0 |
27 /27 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NP418 epitope from 1972 influenza strain[9 aa] | A | 77.8 /92.0 |
27 /27 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NP418 epitope from 1977 influenza strain[9 aa] | A | 78.6 /92.0 |
28 /28 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NP418 epitope from 2009 swine-influenza strain[9 a.. | A | 75.0 /92.0 |
28 /28 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NP418 epitope from 1980 influenza strain[9 aa] | A | 75.0 /92.0 |
28 /28 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | alpha chain of the TK3 TCR[200 aa] | A | 71.4 /92.0 |
7 /7 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9YYU8_9HIV1 Peptide from Protein Nef[11 aa] | A | 72.4 /92.0 |
29 /29 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | EBNA1_EBVB9 Epstein-Barr nuclear antigen 1[11 aa] | A | 71.9 /92.0 |
32 /32 |
C5MK56_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | EBNA1_EBVA8 Epstein-Barr nuclear antigen 1[11 aa] | A | 81.5 /92.4 |
27 /27 |
C5MK56_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | clone12 TCR beta chain[203 aa] | A | 80.0 /92.0 |
10 /10 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | clone12 TCR alpha chain[241 aa] | A | 100.0 /92.0 |
4 /4 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | PP65_HCMVT IPS peptide from CMV, IPSINVHHY[9 aa] | A | 71.4 /92.0 |
28 /28 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S2 peptide[9 aa] | A | 71.0 /92.0 |
31 /31 |
Q546I9_HUMAN HLA class I histocompatibility antigen B, alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POL_HV1B1 Reverse transcriptase peptide NPDIVIYQY[9 aa] | A | 78.1 /93.1 |
32 /32 |
MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POL_HV1B1 Reverse transcriptase peptide NPDIVIYQY[8 aa] | A | 75.9 /92.0 |
29 /29 |
F4NBT5_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | An HIV reverse transcriptase epitope[9 aa] | A | 80.0 /91.7 |
25 /25 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | SB27 T cell receptor beta chain[241 aa] | A | 83.3 /92.4 |
6 /6 |
HLA-B35 variant |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | The Delta chain of TU55 TCR[203 aa] | A | 80.0 /91.7 |
5 /5 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | VAL-PRO-LEU-THR-GLU-ASP-ALA-GLU-LEU[9 aa] | A | 75.0 /92.0 |
28 /28 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Q6IRV4_HUMAN TCR 589 alpha chain[203 aa] | C | 80.0 /91.9 |
10 /10 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | K7N5M4_HUMAN TCR 589 beta chain[241 aa] | C | 75.0 /91.9 |
8 /8 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PEPTIDE LPPLDITPY[9 aa] | A | 69.2 /92.1 |
26 /26 |
1B35_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-35 B*350.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PEPTIDE VPLRPMTY[8 aa] | A | 69.2 /91.7 |
26 /26 |
1B35_HUMAN HLA class I histocompatibility antigen, BW-53 B*53.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 8-mer peptide[8 aa] | A | 73.1 /91.7 |
26 /26 |
A0A890UPS4_HUMAN MHC class I protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 4-mer lipopeptide[4 aa] | A | 90.9 /91.6 |
11 /11 |
A0A890UPS4_HUMAN MHC class I protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | KI2L2_HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2[197 aa] | A | 83.3 /91.0 |
12 /12 |
HLA-CW3 (HEAVY CHAIN) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LEU-ASN-PRO-SER-VAL-ALA-ALA-THR-LEU[9 aa] | A | 73.1 /91.6 |
26 /26 |
F6IQA6_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 10-mer peptide[10 aa] | A | 76.9 /91.2 |
26 /26 |
C1K0Y1_HUMAN HLA class I antigen, Cw8.2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN GLY-ALA-ASP-GLY-VAL-GLY-LYS-SER-ALA-LEU[10 aa] | A | 85.2 /91.2 |
27 /27 |
C1K0Y1_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TCR-V-alpha-12-02*01[193 aa] | E | 85.7 /91.2 |
7 /7 |
C1K0Y1_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR-V-beta-10-2*01[238 aa] | E | 50.0 /91.2 |
2 /2 |
C1K0Y1_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 9-mer peptide[9 aa] | A | 79.2 /91.2 |
24 /24 |
C1K0Y1_HUMAN HLA class I antigen, Cw8.2 alpha chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN GLY-ALA-ASP-GLY-VAL-GLY-LYS-SER-ALA[9 aa] | A | 79.2 /91.2 |
24 /24 |
C1K0Y1_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | IMA2_HUMAN PEPTIDE FROM IMPORTIN ALPHA-2[9 aa] | A | 76.9 /91.0 |
26 /26 |
HLA-CW3 (HEAVY CHAIN) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POL_HV1U4 HIV-1 PEPTIDE (LPPVVAKEI)[9 aa] | A | 73.9 /90.9 |
23 /23 |
1B49_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN HEAVY CHAIN.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | NP338 peptide[9 aa] | A | 75.0 /93.5 |
28 /28 |
1B18_HUMAN HLA class I histocompatibility antigen, B-18 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NP338-L7S peptide[9 aa] | A | 58.1 /90.9 |
31 /31 |
1B37_HUMAN HLA class I histocompatibility antigen, B-37 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NP338-V6L peptide[9 aa] | A | 58.1 /90.9 |
31 /31 |
1B37_HUMAN HLA class I histocompatibility antigen, B-37 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | EM2 TCR alpha chain[193 aa] | A | 100.0 /90.9 |
6 /6 |
1B37_HUMAN HLA class I histocompatibility antigen, B-37 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | EM2 TCR beta chain[237 aa] | A | 88.9 /90.9 |
9 /9 |
1B37_HUMAN HLA class I histocompatibility antigen, B-37 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POL_HV1Z2 PEPTIDE[8 aa] | A | 65.2 /90.6 |
23 /23 |
1B49_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN HEAVY CHAIN.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POL_HV1Z2 peptid from Gag-Pol polyprotein[8 aa] | A | 70.8 /90.6 |
24 /24 |
1B52_HUMAN HLA class I histocompatibility antigen, B-52 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T-Cell Receptor Chain alpha[192 aa] | A | 92.3 /90.9 |
13 /13 |
1B51_HUMAN HLA class I histocompatibility antigen, B-51 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T-cell Receptor Beta chain[240 aa] | A | 90.9 /90.9 |
11 /11 |
1B51_HUMAN HLA class I histocompatibility antigen, B-51 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | D9J353_9INFA Matrix protein 1[9 aa] | A | 73.1 /90.8 |
26 /26 |
1C08_HUMAN HLA class I histocompatibility antigen, Cw-8 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 87.5 /89.9 |
32 /32 |
1B53_HUMAN HLA class I histocompatibility antigen, BW-53 B*53.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2 microglobulin[100 aa] | E | 100.0 /88.7 |
3 /3 |
1C04_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, CW-4 CW*04.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 100.0 /100.0 |
33 /33 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | B2MG_HUMAN Beta-2-microglobulin[99 aa] | D | 100.0 /88.0 |
3 /3 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_HUMAN Beta-2-microglobulin[99 aa] | A | 89.7 /92.8 |
29 /29 |
A0A2R7Z5J3_HUMAN Lymphocyte antigen HLA-B27 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | beta chain C12C TCR[248 aa] | A | 75.0 /92.8 |
4 /4 |
1B27_HUMAN HLA class I histocompatibility antigen, B-27 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Beta Chain of C3 TCR[243 aa] | A | 100.0 /90.1 |
8 /8 |
S6BVK3_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | T cell receptor beta[240 aa] | A | 66.7 /90.5 |
9 /9 |
F6IQM2_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | SB47 TCR beta chain[242 aa] | A | 100.0 /92.4 |
6 /6 |
C5MK56_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR-V-beta-5-6*01[240 aa] | A | 66.7 /91.2 |
3 /3 |
C1K0Y1_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TCR9a beta chain[241 aa] | C | 100.0 /90.5 |
9 /9 |
A0A7T3RIQ2_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SER-ALA-GLU-PRO-VAL-PRO-LEU-GLN-LEU[9 aa] | A | 65.2 /90.5 |
23 /23 |
1C05_HUMAN HLA class I histocompatibility antigen, Cw-5 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | VAL-ARG-SER-ARG-ARG-ABA-LEU-ARG-LEU[9 aa] | A | 65.4 /90.5 |
26 /26 |
1C06_HUMAN HLA class I histocompatibility antigen, Cw-6 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | VAL-ARG-SER-ARG-ARG-ABA-LEU-ARG-LEU[9 aa] | A | 69.0 /90.5 |
29 /29 |
F6IQM2_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | ALA-ARG-THR-GLU-LEU-TYR-ARG-SER-LEU[9 aa] | A | 64.0 /90.5 |
25 /25 |
1C06_HUMAN HLA class I histocompatibility antigen, Cw-6 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR-V-alpha-4*01[189 aa] | A | 72.7 /91.2 |
11 /11 |
C1K0Y1_HUMAN HLA class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
A | TCR9a alpha chain[186 aa] | C | 100.0 /90.5 |
1 /1 |
A0A7T3RIQ2_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | KRAS-G12D-9mer with A18L substitution[9 aa] | C | 73.9 /90.5 |
23 /23 |
A0A7T3RIQ2_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | T cell receptor alpha[184 aa] | A | 83.3 /90.5 |
6 /6 |
F6IQM2_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | ALA-ARG-PHE-ASN-ASP-LEU-ARG-PHE-VAL[9 aa] | A | 64.0 /90.5 |
25 /25 |
1C06_HUMAN HLA class I histocompatibility antigen, Cw-6 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | GLN-ALA-SER-GLN-GLU-VAL-LYS-ASN-TRP[9 aa] | A | 59.3 /89.9 |
27 /27 |
HLA-B*58:01 Heavy Chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Alpha chain of C3 TCR[200 aa] | A | 83.3 /90.1 |
6 /6 |
S6BVK3_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | P[9 aa] | A | 69.0 /90.0 |
29 /29 |
Heavy Chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PEPTIDE TPYDINQML[9 aa] | A | 68.0 /89.9 |
25 /25 |
1B53_HUMAN HLA class I histocompatibility antigen, BW-53 B*53.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PEPTIDE LS6 (KPIVQYDNF)[9 aa] | A | 65.4 /89.9 |
26 /26 |
1B53_HUMAN HLA class I histocompatibility antigen, BW-53 B*53.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | GLN-ALA-THR-GLN-GLU-VAL-LYS-ASN-TRP[9 aa] | A | 60.9 /89.9 |
23 /23 |
1B58_HUMAN HLA class I histocompatibility antigen, B-58 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | GLN-ALA-SER-GLN-ASP-VAL-LYS-ASN-TRP[9 aa] | A | 55.2 /89.9 |
29 /29 |
1B58_HUMAN HLA class I histocompatibility antigen, B-58 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Decapeptide: THR-SER-THR-PHE-GLU-ASP-VAL-LYS-ILE-L.. | A | 54.2 /89.9 |
24 /24 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Decapeptide: THR-SER-THR-LEU-GLN-GLU-GLN-ILE-GLY-T.. | A | 53.8 /89.8 |
26 /26 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Nonamer peptide: LEU-THR-VAL-GLN-VAL-ALA-ARG-VAL-T.. | A | 62.5 /89.9 |
24 /24 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | HIV peptide RKV[8 aa] | B | 62.1 /89.9 |
29 /29 |
U6BR87_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | THR-SER-MET-SER-PHE-VAL-PRO-ARG-PRO-TRP[10 aa] | A | 65.2 /89.9 |
23 /23 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LEU-SER-ASP-SER-THR-ARG-ASP-VAL-THR-TRP[10 aa] | A | 59.3 /89.9 |
27 /27 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GLY-SER-PHE-ASP-TYR-SER-GLY-VAL-HIS-LEU-TRP[11 aa].. | A | 65.2 /89.9 |
23 /23 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LEU-ALA-LEU-LEU-THR-GLY-VAL-ARG-TRP[9 aa] | A | 64.0 /89.9 |
25 /25 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Peptide ALA-SER-LEU-ASN-LEU-PRO-ALA-VAL-SER-TRP[10.. | A | 61.9 /89.9 |
21 /21 |
U6BR87_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV-P24[9 aa] | A | 60.9 /89.8 |
23 /23 |
1B57_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LSSPVTKSF[9 aa] | A | 60.0 /89.8 |
25 /25 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | pep-V[9 aa] | A | 68.2 /89.8 |
22 /22 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | KI3L1_HUMAN Killer cell immunoglobulin-like receptor 3DL1[281 .. | A | 88.2 /89.8 |
17 /17 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 10-mer peptide[10 aa] | A | 69.6 /89.8 |
23 /23 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 10-mer peptide[10 aa] | A | 64.0 /89.8 |
25 /25 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Decapeptide: SER-SER-THR-ARG-GLY-ILE-SER-GLN-LEU-T.. | A | 58.1 /89.8 |
31 /31 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Decapeptide: THR-SER-THR-THR-SER-VAL-ALA-SER-SER-T.. | A | 58.3 /89.8 |
24 /24 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Decapeptide: THR-SER-ASN-LEU-GLN-GLU-GLN-ILE-GLY-T.. | A | 64.0 /89.8 |
25 /25 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV peptide RKV-Kyn[6 aa] | A | 63.3 /89.8 |
30 /30 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q70A02_9HIV1 GAG PROTEIN[11 aa] | A | 68.0 /89.8 |
25 /25 |
1B57_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HIV-P24[9 aa] | A | 63.0 /89.8 |
27 /27 |
1B57_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | AGA T-CELL RECEPTOR ALPHA CHAIN[199 aa] | A | 70.0 /89.8 |
10 /10 |
1B57_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | AGA T-CELL RECEPTOR BETA CHAIN[238 aa] | A | 80.0 /89.8 |
5 /5 |
1B57_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | VAL-THR-THR-ASP-ILE-GLN-VAL-LYS-VAL[9 aa] | A | 62.5 /89.7 |
24 /24 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LYS-ALA-GLY-GLN-VAL-VAL-THR-ILE-TRP[9 aa] | A | 63.0 /89.5 |
27 /27 |
F4NC28_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | VAL-SER-PHE-ILE-GLU-PHE-VAL-GLY-TRP[9 aa] | A | 57.7 /89.5 |
26 /26 |
F4NC28_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | LYS-ALA-GLY-GLN-VAL-VAL-THR-ILE[8 aa] | A | 60.0 /89.5 |
20 /20 |
A0A1J0KHA6_HUMAN HLA-B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | VAL-SER-PHE-ILE-GLU-PHE-VAL-ILE[8 aa] | A | 59.1 /89.5 |
22 /22 |
A0A1J0KHA6_HUMAN HLA-B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Nonamer peptide: LEU-SER-SER-PRO-VAL-THR-LYS-SER-T.. | A | 64.0 /89.9 |
25 /25 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Nonamer peptide: LEU-THR-VAL-GLN-VAL-ALA-ARG-VAL-T.. | A | 63.0 /89.9 |
27 /27 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q1M075_9HIV1 Gag protein[11 aa] | A | 66.7 /89.4 |
21 /21 |
Q9MYI6_HUMAN HLA class I histocompatibility antigen B-57 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q1KW74_9HIV1 Gag protein[11 aa] | A | 63.6 /89.4 |
22 /22 |
Q9MYI6_HUMAN HLA class I histocompatibility antigen B-57 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ARG-TYR-ARG-PRO-GLY-THR-VAL-ALA-LEU[9 aa] | A | 66.7 /89.1 |
30 /30 |
B4DVY0_HUMAN cDNA FLJ54183, highly similar to HLA class I histo.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | KI2L3_HUMAN Killer cell immunoglobulin-like receptor 2DL3[167 .. | A | 83.3 /89.2 |
12 /12 |
1C07_HUMAN HLA class I histocompatibility antigen, Cw-7 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCA_HUMAN TcR alpha chain[201 aa] | A | 81.8 /95.7 |
11 /11 |
1B08_HUMAN MHC heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCB_HUMAN TcR beta chain[241 aa] | A | 100.0 /95.7 |
9 /9 |
1B08_HUMAN MHC heavy chain |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | EBNA6_EBV EBV decapeptide epitope[10 aa] | A | 58.6 /88.8 |
29 /29 |
1B44_HUMAN HLA class I histocompatibility complex HLA-B*4402 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DM1 T cell receptor alpha chain[199 aa] | A | 100.0 /89.1 |
7 /7 |
1B44_HUMAN HLA class I histocompatibility complex HLA-B*4402 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | DM1 T cell receptor beta chain[244 aa] | A | 85.7 /89.1 |
7 /7 |
1B44_HUMAN HLA class I histocompatibility complex HLA-B*4402 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | EEYLQAFTY, self peptide from the ATP binding casse.. | A | 55.9 /88.8 |
34 /34 |
1B44_HUMAN HLA class I histocompatibility antigen, B-44 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | EEYLKAWTF, mimotope peptide[9 aa] | A | 60.0 /88.8 |
30 /30 |
1B44_HUMAN HLA class I histocompatibility antigen, B-44 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ARG-GLN-ASP-ILE-LEU-ASP-LEU-TRP-ILE[9 aa] | A | 55.6 /89.1 |
27 /27 |
F4YTC6_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HLA-Cw4-specific peptide[9 aa] | A | 68.0 /88.7 |
25 /25 |
1C04_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, CW-4 CW*04.. |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | HLA-Cw4-specific peptide[9 aa] | A | 50.0 /88.7 |
2 /2 |
1C04_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, CW-4 CW*04.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HLA-CW4 SPECIFIC PEPTIDE[9 aa] | A | 63.0 /89.0 |
27 /27 |
1C04_HUMAN HISTOCOMPATIBILITY LEUKOCYTE ANTIGEN (HLA)-CW4 (HE.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SNX5_HUMAN Sorting nexin 5[9 aa] | A | 57.6 /88.8 |
33 /33 |
1B44_HUMAN leukocyte antigen (HLA) class I molecule |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q95HB9_HUMAN peptide from HLA-DPA1 protein[9 aa] | A | 54.5 /88.8 |
33 /33 |
1B44_HUMAN HLA class I histocompatibility antigen, B-44 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q95HB9_HUMAN peptide from HLA-DPA1 protein[9 aa] | A | 56.7 /88.8 |
30 /30 |
1B44_HUMAN HLA class I histocompatibility antigen, B-44 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q95HB9_HUMAN peptide from HLA-DPA1 protein[9 aa] | A | 60.0 /88.8 |
30 /30 |
1B44_HUMAN HLA class I histocompatibility antigen, B-44 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q95HB9_HUMAN peptide from HLA-DPA1 protein[9 aa] | A | 54.8 /88.8 |
31 /31 |
1B44_HUMAN HLA class I histocompatibility antigen, B-44 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q95HB9_HUMAN peptide from HLA-DPA1 protein[9 aa] | A | 55.2 /88.8 |
29 /29 |
1B44_HUMAN HLA class I histocompatibility antigen, B-44 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | BZLF1_EBVG Trans-activator protein BZLF1[12 aa] | A | 57.6 /88.8 |
33 /33 |
1B44_HUMAN HLA class I histocompatibility antigen, B-44 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | KI2L1_HUMAN KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR 2DL1[195 .. | A | 75.0 /88.7 |
12 /12 |
1C04_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, CW-4 CW*04.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | HLA DPA*0201 peptide[9 aa] | A | 56.7 /88.8 |
30 /30 |
1B44_HUMAN HLA class I histocompatibility antigen, BW-44(B-12.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TPSN_HUMAN Tapasin[364 aa] | D | 90.9 /88.0 |
11 /11 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TPSN_HUMAN Tapasin[361 aa] | A | 94.4 /88.7 |
36 /36 |
HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | EEFGRC peptide[6 aa] | A | 50.0 /88.7 |
24 /24 |
HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | GL dipeptide[2 aa] | A | 62.5 /88.7 |
8 /8 |
HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | B2MG_HUMAN Beta-2-microglobulin[88 aa] | A | 88.9 /88.7 |
18 /18 |
HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha[181 aa] | A | 58.3 /88.4 |
12 /12 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | AZOBENZENE-CONTAINING PEPTIDE[7 aa] | A | 53.8 /88.4 |
13 /13 |
1A11_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-11 ALPHA.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | Heavy chain[216 aa] | A | 90.0 /88.3 |
10 /10 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | Light chain[216 aa] | A | 75.0 /88.3 |
4 /4 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike protein S1 peptide[9 aa] | A | 64.0 /88.4 |
25 /25 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha[191 aa] | A | 58.3 /88.4 |
12 /12 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | M1_INBAC Matrix protein 1 peptide SALEWIKNK[9 aa] | A | 61.5 /88.4 |
26 /26 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_CVHSA SARS NUCLEOCAPSID PEPTIDE[9 aa] | A | 65.5 /88.4 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | DNA polymerase PEPTIDE HOMOLOGUE[10 aa] | A | 56.0 /88.3 |
25 /25 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | R4P6M5_9INFA Nucleocapsid protein[11 aa] | A | 55.6 /88.3 |
27 /27 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | R4X2K3_9INFA Nucleoprotein[11 aa] | A | 52.0 /88.3 |
25 /25 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | A14_VACCW peptide from Virion membrane protein A14[9 aa] | C | 56.7 /88.3 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Epstein Barr Virus, Latent membrane protein 2 epit.. | A | 65.4 /88.3 |
26 /26 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Epstein Barr Virus, Latent Membrane Protein 2 epit.. | A | 69.2 /88.3 |
13 /13 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Epstein Barr Virus, Latent Membrane Protein 2 epit.. | A | 45.5 /88.3 |
11 /11 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Epstein Barr Virus, Latent membrane protein-2 epit.. | A | 66.7 /88.3 |
18 /18 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GTS1 peptide[10 aa] | A | 66.7 /88.3 |
27 /27 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GTS3 peptide[10 aa] | A | 60.0 /88.3 |
30 /30 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | A0A087WSZ9_HUMAN K7N5N2_HUMAN T-cell receptor alpha variable 30,T-cell receptor,.. | A | 25.0 /88.3 |
4 /4 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | MTB[9 aa] | A | 48.3 /88.3 |
29 /29 |
HLA-A*3003 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NP44[9 aa] | A | 50.0 /88.3 |
28 /28 |
HLA-A*3003 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ALA-THR-ILE-GLY-THR-ALA-MET-TYR-LYS[9 aa] | A | 59.3 /88.3 |
27 /27 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ALA-THR-ILE-GLY-THR[5 aa] | A | 53.8 /88.3 |
13 /13 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | ALA-MET-TYR-LYS[4 aa] | A | 46.2 /88.3 |
13 /13 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[7 aa] | D | 65.2 /88.3 |
23 /23 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[6 aa] | G | 63.6 /88.3 |
22 /22 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[8 aa] | A | 63.6 /88.4 |
22 /22 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR beta[246 aa] | A | 80.0 /88.4 |
5 /5 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN KRAS G12D peptide (VVVGADGVGK)[10 aa] | A | 69.2 /88.4 |
26 /26 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha[163 aa] | A | 60.0 /88.3 |
10 /10 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_INBSI Nucleoprotein peptide KTNGNAFIGK[10 aa] | A | 64.3 /88.4 |
28 /28 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NS1_INBSJ Non-structural protein 1 peptide RVLVNGTFLK[10 aa].. | A | 58.1 /88.3 |
31 /31 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POL_HV1Z2 nonamer reverse transcriptase (AIFQSSMTK)[9 aa] | A | 58.6 /88.4 |
29 /29 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | peptide[9 aa] | A | 51.9 /88.3 |
27 /27 |
F6IQY1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NEF_HV1Z6 Negative factor[10 aa] | A | 60.7 /88.4 |
28 /28 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MYPR_HUMAN MYELIN PROTEOLIPID PROTEIN[9 aa] | A | 53.8 /88.0 |
26 /26 |
1A03_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-3 ALPHA .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E | CALR_HUMAN Calreticulin[365 aa] | D | 100.0 /88.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E | CALR_HUMAN Calreticulin[364 aa] | D | 100.0 /88.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PK3CA_HUMAN wild-type PIK3CA peptide[9 aa] | A | 62.5 /88.0 |
24 /24 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | T cell receptor, alpha chain[187 aa] | A | 83.3 /88.0 |
6 /6 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | T cell receptor, beta chain[247 aa] | A | 75.0 /88.0 |
12 /12 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TPSN_HUMAN Tapasin[348 aa] | D | 92.3 /88.0 |
26 /26 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
C | PDIA3_HUMAN Protein disulfide-isomerase A3[459 aa] | D | 0.0 /88.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | CF34 beta chain[247 aa] | A | 81.8 /95.7 |
11 /11 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | DD31 TCR beta chain[243 aa] | A | 100.0 /95.7 |
4 /4 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | PK3CA_HUMAN mutant PIK3CA peptide[9 aa] | A | 60.7 /88.0 |
28 /28 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | T cell receptor, alpha chain[185 aa] | A | 50.0 /87.9 |
10 /10 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9YRL8_HCMV Major immediate-early protein[9 aa] | A | 78.8 /95.7 |
33 /33 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CMV peptide[9 aa] | A | 78.1 /87.8 |
32 /32 |
D2KZ37_HUMAN HLA-A*02:01 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_INBAC Nucleoprotein peptide[9 aa] | A | 60.0 /87.7 |
25 /25 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASN_HUMAN KRAS peptide (VVVGAGGVGK)[10 aa] | A | 60.9 /88.3 |
23 /23 |
A0A583ZB34_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | VAL-VAL-VAL-GLY-ALA-GLY-GLY-VAL-GLY-LYS[10 aa] | A | 69.6 /87.7 |
23 /23 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NCAP_I46A1 Nucleoprotein peptide[9 aa] | A | 56.7 /87.7 |
30 /30 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Fab light chain[213 aa] | A | 100.0 /100.0 |
6 /6 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | IgG, Fab Light Chain V2[214 aa] | D | 62.5 /87.7 |
8 /8 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | IgG, Fab Heavy Chain V2[216 aa] | D | 87.5 /87.7 |
16 /16 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | KRAS G12V (7-16)[10 aa] | D | 63.2 /87.7 |
19 /19 |
HLAA_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | peptide KRAS-G12V-9[9 aa] | A | 63.6 /87.6 |
22 /22 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | TCR alpha chain[198 aa] | A | 55.6 /87.6 |
9 /9 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | TCR beta chain[240 aa] | A | 60.0 /87.6 |
10 /10 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | TCR alpha chain[194 aa] | C | 76.9 /87.6 |
13 /13 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TCR beta chain[242 aa] | C | 71.4 /87.6 |
7 /7 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RASK_HUMAN KRAS-G12wt-9[9 aa] | A | 60.0 /87.6 |
25 /25 |
U5YJJ6_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTNB1_HUMAN Catenin beta-1[9 aa] | A | 65.2 /87.5 |
23 /23 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CTNB1_HUMAN Catenin beta-1[9 aa] | A | 68.2 /87.4 |
22 /22 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 8-mer model peptide[8 aa] | A | 59.3 /87.0 |
27 /27 |
A0A109QAI7_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 4-mer lipopeptide[5 aa] | A | 60.0 /86.6 |
20 /20 |
A0A411J078_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | RDRP_I97A1 PB1 peptide[8 aa] | A | 56.7 /86.6 |
30 /30 |
A0A411J078_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TERT_HUMAN Telomerase reverse transcriptase[9 aa] | A | 54.5 /86.3 |
22 /22 |
1A24_HUMAN HLA class I histocompatibility antigen, A-24 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | POL_SIVSP peptide of Gag-Pol polyprotein[9 aa] | A | 60.0 /86.2 |
25 /25 |
Q30597_MACMU MHC class I Mamu-A*02 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B2MG_MACMU Beta-2-microglobulin[100 aa] | A | 89.7 /86.2 |
29 /29 |
Q30597_MACMU MHC class I Mamu-A*02 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Q9WH73_SIVCZ peptide of Protein Nef[9 aa] | A | 64.5 /86.2 |
31 /31 |
Q30597_MACMU MHC class I Mamu-A*02 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | NP44-S7N mutant peptide, CTELKLNDY[9 aa] | C | 46.4 /86.2 |
28 /28 |
1A01_HUMAN HLA class I histocompatibility antigen, A-1 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | MAG1_HUMAN MELANOMA-ASSOCIATED ANTIGEN 1[9 aa] | A | 55.6 /86.1 |
27 /27 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | HYB3 HEAVY CHAIN[223 aa] | A | 66.7 /86.1 |
9 /9 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | HYB3 LIGHT CHAIN[210 aa] | A | 66.7 /86.1 |
6 /6 |
1A01_HUMAN HLA CLASS I HISTOCOMPATIBILITY ANTIGEN |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
362 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
NHE
|
A | 100.0 /100.0 |
7 /7 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
12P
|
A | 100.0 /100.0 |
11 /11 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
PE8
|
A | 100.0 /100.0 |
4 /4 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
BTB
|
A | 54.5 /93.1 |
11 /11 |
MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
ARG
|
A | 66.7 /92.7 |
9 /9 |
O78189_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
ARG
|
C | 100.0 /92.7 |
5 /5 |
O78189_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
1KX
|
A | 63.6 /89.8 |
11 /11 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
1KX
|
A | 70.0 /89.8 |
10 /10 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
362 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U |
IOD
|
A | 66.7 /92.4 |
3 /3 |
HLA-B35 variant |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
IOD
|
A | 100.0 /92.4 |
2 /2 |
HLA-B35 variant |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
IOD
|
A | 100.0 /92.4 |
2 /2 |
HLA-B35 variant |
![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
IOD
|
F | 100.0 /92.4 |
1 /1 |
HLA-B35 variant |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
PA |
IOD
|
P | 50.0 /92.4 |
2 /2 |
HLA-B35 variant |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
IOD
|
C | 100.0 /92.0 |
2 /2 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
S |
IOD
|
A | 100.0 /95.7 |
1 /1 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
IOD
|
F | 100.0 /95.7 |
1 /1 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
K
|
A | 100.0 /100.0 |
1 /1 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
QA |
K
|
A | 100.0 /100.0 |
1 /1 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S |
K
|
A | 100.0 /100.0 |
2 /2 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
K
|
A | 100.0 /100.0 |
5 /5 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
U |
K
|
A | 100.0 /100.0 |
1 /1 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
K
|
A | 100.0 /100.0 |
2 /2 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
KA |
K
|
C | 100.0 /100.0 |
3 /3 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
LA |
K
|
C | 100.0 /100.0 |
2 /2 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
MA |
K
|
C | 100.0 /100.0 |
1 /1 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
NA |
K
|
C | 100.0 /100.0 |
1 /1 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
CD
|
A | 100.0 /95.7 |
3 /3 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MN
|
A | 100.0 /92.8 |
1 /1 |
Q29846 HUMAN LYMPHOCYTE ANTIGEN HLA-B27 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
NI
|
A | 100.0 /100.0 |
3 /3 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
NI
|
A | 100.0 /100.0 |
4 /4 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
CU
|
A | 66.7 /92.8 |
3 /3 |
1B27_HUMAN HLA class I histocompatibility antigen, B-27 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
CU
|
A | 100.0 /92.8 |
2 /2 |
1B27_HUMAN HLA class I histocompatibility antigen, B-27 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
CU
|
A | 100.0 /92.8 |
1 /1 |
1B27_HUMAN HLA class I histocompatibility antigen, B-27 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
PO4
|
A | 50.0 /92.0 |
2 /2 |
Q546I9_HUMAN HLA class I histocompatibility antigen B, alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
PO4
|
A | 100.0 /92.0 |
5 /5 |
Q546I9_HUMAN HLA class I histocompatibility antigen B, alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
NA
|
A | 100.0 /92.8 |
1 /1 |
1B27_HUMAN HLA class I histocompatibility antigen, B-27 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
NA
|
A | 100.0 /95.7 |
3 /3 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
NA
|
A | 100.0 /95.7 |
4 /4 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
GA |
NA
|
F | 100.0 /95.7 |
1 /1 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
NA
|
A | 100.0 /95.2 |
4 /4 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
NA
|
A | 66.7 /95.7 |
6 /6 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
NA
|
A | 100.0 /93.8 |
3 /3 |
1B46_HUMAN HLA class I histocompatibility antigen, B-46 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
NA
|
A | 75.0 /93.8 |
4 /4 |
1B46_HUMAN HLA class I histocompatibility antigen, B-46 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
NA
|
A | 100.0 /100.0 |
1 /1 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
NA
|
A | 100.0 /100.0 |
3 /3 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
NA
|
D | 100.0 /100.0 |
1 /1 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
NA
|
A | 66.7 /93.1 |
3 /3 |
A0MSS3_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
NA
|
A | 100.0 /93.1 |
2 /2 |
F4NBQ1_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
NA
|
A | 100.0 /100.0 |
1 /1 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GA |
NA
|
C | 100.0 /100.0 |
4 /4 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
NA
|
A | 100.0 /88.4 |
2 /2 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
NA
|
A | 100.0 /92.0 |
3 /3 |
Q546I9_HUMAN HLA class I histocompatibility antigen B, alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
NA
|
A | 50.0 /92.0 |
2 /2 |
Q546I9_HUMAN HLA class I histocompatibility antigen B, alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
MG
|
A | 100.0 /88.4 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MG
|
D | 100.0 /88.4 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
MG
|
D | 100.0 /88.4 |
1 /1 |
U5YJK1_HUMAN HLA class I histocompatibility antigen, A alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
MG
|
C | 100.0 /90.5 |
2 /2 |
A0A7T3RIQ2_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
L |
CL
|
A | 100.0 /95.7 |
1 /1 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
CL
|
A | 100.0 /95.7 |
1 /1 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
CL
|
A | 100.0 /95.7 |
2 /2 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
CL
|
F | 100.0 /95.7 |
3 /3 |
1B08_HUMAN HLA class I histocompatibility antigen, B-8 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
CL
|
A | 100.0 /89.8 |
1 /1 |
1B57_HUMAN HLA class I histocompatibility antigen, B-57 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
CL
|
A | 50.0 /92.4 |
2 /2 |
C5MK56_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
CL
|
A | 0.0 /93.1 |
1 /1 |
U6BN38_HUMAN HLA class I histocompatibility antigen, B-27 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
CL
|
A | 0.0 /88.3 |
2 /2 |
1A11_HUMAN HLA class I histocompatibility antigen, A-11 alpha.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CL
|
A | 100.0 /100.0 |
1 /1 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
CL
|
A | 100.0 /100.0 |
2 /2 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CL
|
A | 100.0 /92.8 |
2 /2 |
A3F718_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
CL
|
A | 100.0 /100.0 |
1 /1 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
CL
|
A | 100.0 /100.0 |
1 /1 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
CL
|
A | 100.0 /100.0 |
3 /3 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
CL
|
A | 100.0 /100.0 |
2 /2 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
CL
|
A | 100.0 /100.0 |
5 /5 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
CL
|
A | 100.0 /100.0 |
4 /4 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
CL
|
A | 100.0 /100.0 |
2 /2 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
JA |
CL
|
C | 100.0 /100.0 |
3 /3 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
ZN
|
A | 50.0 /89.1 |
2 /2 |
B4DVY0_HUMAN cDNA FLJ54183, highly similar to HLA class I histo.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
E |
ZN
|
A | 100.0 /89.1 |
2 /2 |
B4DVY0_HUMAN cDNA FLJ54183, highly similar to HLA class I histo.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
ZN
|
A | 100.0 /100.0 |
2 /2 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
ZN
|
C | 100.0 /91.9 |
1 /1 |
1B35_HUMAN HLA class I histocompatibility antigen, B-35 alpha.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
ZN
|
A | 100.0 /100.0 |
4 /4 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
ZN
|
A | 100.0 /100.0 |
3 /3 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
ZN
|
A | 100.0 /100.0 |
3 /3 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() |
![]() |
K |
ZN
|
A | 100.0 /100.0 |
4 /4 |
HLAB_HUMAN HLA class I histocompatibility antigen, B alpha ch.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
ZN
|
A | 66.7 /86.6 |
3 /3 |
A0A411J078_HUMAN MHC class I antigen |
![]() ![]() ![]() ![]() ![]() |
![]() |
G |
ZN
|
A | 100.0 /87.0 |
1 /1 |
A0A109QAI7_HUMAN MHC class I antigen |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
362 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | beta-D-fructofuranose-(2-1)-alpha-D-glucopyranose | A | 100.0 /100.0 |
3 /3 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | beta-D-fructofuranose-(2-1)-alpha-D-glucopyranose | A | 100.0 /100.0 |
5 /5 |
1B07_HUMAN HLA class I histocompatibility antigen, B-7 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /88.0 |
4 /4 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
![]() ![]() ![]() ![]() ![]() |
![]() |
G | alpha-D-glucopyranose-(1-3)-alpha-D-mannopyranose-.. | D | 100.0 /88.0 |
1 /1 |
1A03_HUMAN HLA class I histocompatibility antigen, A-3 alpha .. |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
362 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | A3F718_HUMAN MHC class I antigen (Fragment)[276 aa] | A | 100.0 /92.8 |
7 /7 |
A3F718_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | A3F718_HUMAN MHC class I antigen (Fragment)[276 aa] | A | 100.0 /92.8 |
9 /9 |
A3F718_HUMAN MHC class I antigen (Fragment) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |